Font Size: a A A

Effects Of Prostaglandin E1 On Endocrine Cardiac Function

Posted on:2006-03-21Degree:MasterType:Thesis
Country:ChinaCandidate:X S JinFull Text:PDF
GTID:2144360155476148Subject:Internal Medicine
Abstract/Summary:PDF Full Text Request
Prostaglandin E1 is an E series prostaglandin produced endogenously by eyelooxygenation of dihomo-X-linolenic acid. In the cardiovascular system. the major function of prostaglandin E1 has been known as vasodilation and antiplalelet aggregation. Atrial natriuretie peptide (ANP) is a potent diuretic and natriuretic hormone, having renal, cardiac as well as endocrinological effects and is secreted predominantly from the atrial myoeytes. The purpose of the present study was to define the direct effect of prostaglandin E1 on the endocrine cardiac function using isolated perfused beating rabbit atria. New Zealand White rabbits of either sex weighting about 1.6 kg were used. An isolated perfused atrial preparation was prepared by the method allowing atrial pacing and measurements of changes in atrial volume during contraction (stroke volume), pulse pressure, transmural extracellular fluid translocation. cAMP and cCiMP efflux and ANP secretion.Prostaglandin E1 significantly increased the concentration of cGMP as well as cAMP. but had no significant effects on atrial dynamics and ANP release. The effects of prostaglandin E1 on cAMP and cGMP production were concentration-dependent. Prosiaglandin E1-induced increase in cGMP production showed a bell-shaped concentration-response curve. Prostaglandin E1-stimulated cGMP production was attenuated by pretreatment with N-nitro-t-arginine methyl ester (L-NAME an inhibitor of nitric oxide synthase) or H-[1.2.4] oxadiazolo [4.3-a] quinoxalin-l-one (ODQ. an inhibitor of soluble guanylyl cyclase). Prostaglandin E1-induced increase in cGMP efflux was blocked by pretreatment with A1123848 (a selective prostaglandin receptor EP4 antagonist) but not by pretreatment with AI16809 (a selectiveproslaglandin recepti>r I"!': antagonist). Prostaglandin Iv> significantly increased Ihe concentration of cGMP as well as CAMP, but had no signillcanl effects on atrial dynamics and ANP release. Isoproterenol (|Vadrenergie receptor agonist) also signilleanlly increased the concentration ol cAMP. accompanied by an increase o\ atrial dynamics and a decrese of ANP secretion in a time-dependent manner.These data suggest that proslaglandin \:.\ increased cCiMP production via N()-sGC pathway by KPj receptor activation. In addition, the present study also indicated prostaglandin 1^ increased cAMP efllu\ without aHeeling atrial dynamics and ANP release.
Keywords/Search Tags:Prostaglandin E, atrial natriuretic peptide cGMP, cAMP, atrial dynamics, atrial stroke volume, pulse pressure, nitrie oxide, guanylyl cyclase
PDF Full Text Request
Related items